News – Page 1096 – Endpoints News

As rivals look to carve up its blockbuster revenue, Novartis’ Cosentyx registers remarkably consistent effect for ...

8 years ago

Amicus scraps a top rare disease drug after it flunks a pivotal test — and shares spike

8 years ago

Scott Gottlieb is closing a big loophole in the orphan drug law

8 years ago

Gene therapy startup Rocket Pharma reverse merges with troubled Inotek after $25M raise

8 years ago

Another senior AstraZeneca exec jumps ship; Aldeyra shares soar on positive mid-stage data

8 years ago

ProQR spins out a new RNA biotech focused on CNS diseases

8 years ago

Alexion is reorganizing R&D, axing 600-plus jobs and moving HQ to Boston as execs prep deal spree

8 years ago

Sage’s quick flip into PhIII crashes as lead drug fails badly for rare type of seizures

8 years ago

WATCH: Scott Gottlieb vows to shake up the FDA, backing a trend toward faster drug development

8 years ago

Onxeo shares blitzed after PhIII liver cancer study flops

8 years ago

Struggling in R&D, GSK lines up an FDA pitch on COPD with mixed data

8 years ago

AbbVie stirs safety jitters after two patients die in ABT-494 study

8 years ago

Regeneron, Sanofi post good PhIII asthma data for Dupixent — but it’s losing its halo

8 years ago

Summit wins $62M BARDA contract, shares surge; Novartis adds new CGRP data

8 years ago

#ESMO17 roundup: Idera shares spike on early TLR9 combo data; Erytech touts pancreatic cancer PhIIb data

8 years ago

Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn't refuse, including $20M in cash

8 years ago

#ESMO17: Roche extends losing streak with a setback for Zelboraf as Novartis combo surges ahead

8 years ago

J&J scraps a multibillion-dollar hepatitis C program after rivals divvy up the market

8 years ago

#ESMO17: Bristol-Myers posts data on an upset checkpoint combo victory in frontline kidney cancer

8 years ago

#ESMO17: Eli Lilly sets the stage for a CDK 4/6 showdown with Pfizer, Novartis — but not exactly to its advantage

8 years ago

Allergan CEO gambles a multibillion-dollar franchise — and his company rep — on a high-stakes bet at an Indian ...

8 years ago

#ESMO17: AstraZeneca salves stinging setback with a big win in a blockbuster segment of the lung cancer market

8 years ago

Roche gets hit with another big R&D setback as a prospective AMD blockbuster flops in PhIII

8 years ago

Prosecutors want Shkreli thrown in jail now after Facebook threat

8 years ago

First page Previous page 1093 1094 109510961097 1098 1099 Next page Last page